Peptide Cycles: How Long to Run Each Peptide

What a Peptide Cycle Actually Is

A cycle is a defined block of administration followed by a defined break. That is the whole concept, and it is simple enough that the interesting question is never what a cycle is but why anyone would run one.

Most of the cycling advice circulating in peptide communities was inherited wholesale from anabolic steroid protocols, where the framework makes sense for a specific reason: exogenous testosterone suppresses the body's own production, so the off period exists to let that axis restart. Peptide secretagogues do the opposite. They stimulate endogenous release rather than replacing it, so there is no axis shutdown to recover from and no peptide equivalent of post cycle therapy.

Once that borrowed logic is set aside, cycle length stops being a fixed number and becomes a function of the individual compound. Some peptides need scheduled breaks, some are pointless to interrupt, and a few actively lose their benefit when stopped. Getting this right saves both money and outcomes.

The Three Legitimate Reasons to Cycle

Almost every defensible cycling decision traces back to one of three reasons, and knowing which one applies tells you the cycle length without having to look it up.

1. Receptor Desensitization

Repeated stimulation of a receptor can reduce its density or its signalling responsiveness, so the same dose produces a smaller effect over time. This is the genuine, mechanism level reason to cycle and it applies mainly to the growth hormone releasing peptides. Hexarelin is the clearest example, with a growth hormone response that is measurably attenuated within about two weeks of continuous daily use. A washout restores responsiveness because the receptor was downregulated, not exhausted.

2. A Finite Biological Endpoint

Some peptides are run to accomplish a task rather than to maintain a state. A tendon either heals or it does not, and once the repair has plateaued, further administration is spending money on a process that has already finished. Healing peptides are cycled in this sense, but the cycle is defined by the tissue rather than by a receptor.

3. Uncertainty About Long Term Safety

For compounds with no long term human safety data, which is most of this space, limiting cumulative exposure is a reasonable precaution in itself. This is the weakest reason in mechanistic terms and the most honest one in practice. It argues for shorter blocks and real breaks with anything novel or thinly studied.

Cycle Length by Peptide Class

The table below summarises the typical protocol lengths reported across the main classes. Treat these as the common starting points rather than fixed rules.

Healing and Repair Peptides

BPC-157 and TB-500 are the two compounds most people encounter first, and they are also the two most often cycled for the wrong reason. Neither shows meaningful receptor desensitization in the available literature. The four to eight week convention exists because that is roughly the timeframe over which soft tissue repair progresses, not because the compound stops working.

The practical implication is that the endpoint should be functional rather than calendar based. If a tendon issue is clearly resolving at week five, finishing the block is reasonable. If nothing has changed by week six, extending to week ten rarely rescues it and the more useful question is whether the original diagnosis was right. The evidence base and realistic timelines for this are covered in the guide to peptides for tendon repair.

The two compounds also behave differently in the vial and in the schedule. BPC-157 is typically dosed daily throughout a block, while TB-500 protocols usually front load with twice weekly administration for four to six weeks before dropping to a lower maintenance frequency. Running them together is common, and the reasoning behind the pairing is set out in TB-500 vs BPC-157.

One caveat that gets lost: a structural repair does not unwind when the peptide stops, but an unaddressed mechanical cause will reproduce the original injury regardless of how many blocks are run. A peptide cycle is not a substitute for fixing load management or technique.

Growth Hormone Secretagogues

This is the class where cycling is genuinely mechanism driven, and where the differences within the class matter more than the class label.

The Desensitizing End

Hexarelin sits at the extreme. Continuous daily use produces a clearly attenuated growth hormone response within about two weeks and a substantially blunted one over the following months, which is why four to six week blocks with a four week minimum washout are standard. GHRP-2 and GHRP-6 desensitize considerably more slowly but still enough that most protocols cap them around eight to twelve weeks.

The Stable End

Ipamorelin is selective for the growth hormone pathway and shows minimal desensitization, so the argument for interrupting it is precautionary rather than mechanistic. GHRH analogs such as sermorelin and CJC-1295 are the most stable of all, and clinical sermorelin use historically ran for months without a scheduled break. Cycling these aggressively is a common way to underperform a protocol for no reason.

MK-677 Is a Different Problem

MK-677 is an orally active secretagogue with a roughly 24 hour half life, so it raises growth hormone and IGF-1 continuously rather than in pulses. The reason to cycle it is not receptor desensitization but metabolic drift: reduced insulin sensitivity, elevated fasting glucose and water retention that accumulate over long uninterrupted runs. Eight to sixteen weeks with a real break, and glucose monitoring on the longer end, is the common approach.

Whichever compound is used, the class level side effect picture and what is worth monitoring is set out in the peptide side effects guide.

Metabolic Peptides: The Class That Is Not Cycled

GLP-1 and dual agonist compounds are the clearest exception to the cycling framework, and applying it to them is a mistake worth calling out directly.

These compounds do not desensitize their receptor in a way that erodes the effect, and they are not accomplishing a finite repair. They maintain a metabolic state, and when administration stops that state reverts. Withdrawal studies consistently show substantial regain of lost weight after discontinuation. There is no washout that preserves the benefit, so a cycling schedule here delivers a repeated pattern of loss and regain rather than a preserved response.

What these protocols do have is a titration schedule, which is sometimes confused with cycling. Dose escalation over four week intervals exists to manage gastrointestinal tolerability, not to time a break. Details are in the semaglutide dosage guide and the tirzepatide dosage guide.

Longevity and Cosmetic Peptides

Longevity compounds follow their own convention, and it is unusually short. Epithalon protocols descend from Russian clinical work that used ten to twenty day courses repeated two or three times a year, rather than continuous administration. The pulsed structure comes from how the original research was designed, not from a desensitization finding, and it is one of the few cases where the standard protocol is genuinely intermittent by design.

Cosmetic peptides sit closer to the healing category. GHK-Cu applied topically for skin remodelling is typically run for eight to twelve weeks because collagen turnover operates on that timescale, and results are assessed at the end of a block rather than continuously. Where these fit in a broader anti aging approach is covered in top peptides for anti-aging.

Structuring the Off Period

The break is the part most protocols get wrong, usually by making it too short to accomplish anything.

For receptor desensitization, the working rule is an off period at least as long as the on period, with four weeks as a practical floor for the GHRP class. Receptor density and signalling sensitivity recover over weeks, so a one week break after a six week block is close to no break at all. Half measures here produce the worst outcome available: an interrupted protocol that still returns to a desensitized receptor.

For healing peptides the off period serves a different function, which is assessment. Three to four weeks without the compound reveals whether the improvement holds independently, and that answer is what determines whether a second block is worth running.

What to Do During the Break

• Keep the non cycling components running. If a GHRH analog is the base and only the GHRP is being cycled, the base continues.
• Take the measurement. Bloodwork, a strength or range of motion test, or photographs. A break without data is a gap rather than a phase.
• Store the remaining vials properly. Reconstituted peptide degrades on a timescale of weeks, so a four week break can outlast the product. The peptide storage guide covers the temperature and shelf life detail.
• Reconstitute fresh on restart. Do not resume a cycle on a vial that has been sitting for a month. Procedure is in how to reconstitute peptides.

Common Cycling Mistakes

• Applying one cycle length to everything. The "eight weeks on, four weeks off" template circulates as universal advice and fits almost nothing precisely. Cycle length follows mechanism.
• Cycling compounds that do not need it. Interrupting a GHRH analog or ipamorelin on a steroid style schedule reduces exposure with no offsetting benefit.
• Off periods that are too short. A one week break does not reverse receptor downregulation that took six weeks to develop.
• Escalating dose instead of taking the break. When a compound stops working because the receptor is desensitized, raising the dose usually increases side effects without restoring the response.
• Starting several compounds at once. If three peptides begin on the same day, no side effect can be attributed to any of them. Introduce one at a time, separated by at least a week.
• Never recording anything. Without a baseline measurement, the end of a cycle produces an impression rather than a result, and the next cycle is designed on that impression.

A structured way to lay out compound selection and block timing before starting is available in the stack builder.

Frequently Asked Questions